D.E. Shaw & Co’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-25,140
Closed -$666K 4359
2013
Q4
$666K Hold
25,140
﹤0.01% 3512
2013
Q3
$690K Hold
25,140
﹤0.01% 3353
2013
Q2
$576K Buy
+25,140
New +$568K ﹤0.01% 3138

Other funds holding EHC

D.E. Shaw & Co's EHC Position: Q1 2026 in Review

D.E. Shaw & Co increased its Encompass Health (EHC) stake by 67% in Q1 2026, buying an estimated $23.3M and bringing the position to 565,355 shares worth $54.7M. The position accounts for 0.03% of the portfolio, ranked #622.

D.E. Shaw & Co first reported a position in EHC in Q2 2013 and has held it in 47 quarters since. The position peaked at $59.5M in Q3 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • D.E. Shaw & Co held 565,355 shares of Encompass Health worth $54.7M as of Q1 2026.
  • D.E. Shaw & Co bought 227,029 Encompass Health shares in Q1 2026, an estimated $23.3M.
  • Encompass Health made up 0.03% of D.E. Shaw & Co's portfolio in Q1 2026, its #622 holding.
  • D.E. Shaw & Co first reported a position in Encompass Health in Q2 2013 and has held it in 47 quarters since.
  • D.E. Shaw & Co's Encompass Health position peaked at $59.5M in Q3 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.